Cite

HARVARD Citation

    Guo, Y. et al. (2022). Efficacy and safety of adding gemtuzumab ozogamicin to conventional chemotherapy for adult acute myeloid leukemia: a systematic review and meta-analysis. Hematology. 27 (1), pp. 53-64. [Online]. 
  
Back to record